Curetopia: Accelerating Rare Disease Cures Using DeSci-Powered Community Medicine

BioDAOs
Medicine
DeSci

Curetopia, the first BioDAO on Solana, is launching today on the Bio Launchpad.

Curetopia will target the $1T+ rare disease market and is being led by Dr. Ethan O. Perlstein, a Y Combinator alum, Harvard PhD and biotech founder who recently brought a rare disease drug to Phase 3 trials. Curetopia will partner with patient families to accelerate rare disease drugs, with value generated from cures flowing back into the DAO.

Join the $CURES auction

User Guide

The Problem

Over 10,000 rare diseases affect 1 in 10 people globally, imposing a $1 trillion economic burden in the U.S. alone. Big Pharma often overlooks these conditions due to smaller market sizes, leaving millions without effective treatments.

The Solution

Curetopia, the first BioDAO on Solana, is a groundbreaking online research collective that accelerates drug development for rare diseases using cryptocurrency and blockchain technology. By empowering patients and their families to directly fund and influence research, Curetopia is creating a new model for community-driven medicine where patients and patient families are in control.

The Team

Dr. Ethan O. Perlstein (Chief Science Officer) Harvard PhD, Y Combinator alum and biotech founder with over a decade of experience in rare disease drug development. Dr. Perlstein previously brought a rare disease drug to Phase 3 trial for just $5 million (compared to typical $100M+ costs) by collaborating directly with patients and their families. Other contributors include PhDs and biotech operators who have led drug repurposing programs and pioneered therapeutic innovations for rare diseases.

The Science

Curetopia leverages innovative approaches to rare disease research:

  1. Model organism screening, particularly yeast-based drug repurposing
  2. Tokenized intellectual property
  3. Community-driven clinical studies

This unique combination allows for rapid, cost-effective drug discovery and development tailored to specific rare diseases.

Learn more about Curetopia’s scientific approach.


Partners

  • Bio Protocol - leading launchpad and liquidity protocol for DeSci projects incubating and accelerating the Curetopia BioDAO 
  • Molecule - platform enabling IP tokenization and continuous funding for rare disease drugs and experiments developed by Curetopia
  • Perlara - preeminent yeast screening lab pioneering new models of drug repurposing 


Roadmap

Highlights include:

  1. $CURES token auction on Solana
  2. Initiation of yeast-powered drug repurposing for AARS2 rare disease
  3. Expand decentralized patient-led clinical studies
  4. Scale drug repurposing to 1,000 rare diseases

Why Rare Diseases?

The cost of curing a rare disease and bringing it through the FDA is ~100x cheaper because of Priority Review Vouchers and Orphan Drug Designation from the FDA. Even more importantly, rare disease drugs have gone to be $B+ blockbusters from translation into the broader public. Curetopia takes advantage of both.

$CURES Auction & Tokenomics

  • The CURES auction takes place on the Bio Launchpad via a capped fair launch community auction on Solana (user guide here)
  • 15% of $CURES initial supply will be sold during the auction at a starting FDV of $3.33M
  • No pre-sale or insiders - 100% fair distribution
  • Participate in the auction with SOL
  • The auction lasts 21 days, concluding March 11, 2025
  • Equal pricing -- all participants receive the same price when the auction settles
  • Tokens purchased in the auction have no lock-up
  • Once the minimum funding threshold of ~$0.5M is reached, the $CURES FDV rises linearly from ~$3.33M, growing as more SOL is swapped into the auction. If the max funding threshold of ~$4M is met, the auction is closed, and the FDV will settle at ~$26.66m
  • 1% of supply will be airdropped to $BIO holders who participate the auction


$CURES Distribution:

  • Treasury reserves - 40%
  • Core Team - 20%
  • Community auction - 15%
  • Community Incentives - 7%
  • Future Token Sales - 10%
  • Service Providers - 7%
  • Airdrop - 1%.

Vesting: 

  • Treasury Reserves require governance votes to be unlocked
  • Core Team: 4y vesting with 1y cliff
  • All other categories have no vesting

Join the $CURES auction

More Resources: